Prakt. lékáren. 2018; 14(2): 86-89 | DOI: 10.36290/lek.2018.059

Urinary tract infection – prevention and self-healing

Olga Svobodová1,2, Miroslav Turjap1
1 Lékárna, Oddělení klinické farmacie, Fakultní nemocnice Ostrava
2 Farmakologický ústav, LF MU Brno

Urinary tract infection is mainly caused by Escherichia coli. The natural presence of E. coli is in the gastrointestinal tract. Theinfection occur when bacteria ascend urethra into the bladder. Bacteril growth leads to urinary tract infection. The possibilityof pharmacological and non-pharmacological prevention and treatment of urinary tract infection is summarized in this article.

Keywords: urinary tract infection, inflamatory, treatment and over‑the‑counter drugs and dietary supplements

Received: February 3, 2016; Accepted: February 22, 2018; Prepublished online: February 22, 2018; Published: June 20, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svobodová O, Turjap M. Urinary tract infection – prevention and self-healing. Praktické lékárenství. 2018;14(2):86-89. doi: 10.36290/lek.2018.059.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Roland A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2003; 49(2): 71-82. Go to original source...
    2. Končický P. Záněty močových cest. [online] dostupné z http://www.cus.cz/pro-pacienty/diagnozy/zanety-mocovych-cest/ 5-12-2017.
    3. McLellan L, Hunstad D. Urinary Tract Infection: Pathogenesis and Outlook. Cell. 2016; 12(11): 946-957. Go to original source...
    4. Naber K, Bergman B, Bishop M, Bjerklund T. Guidelines EAU pro diagnostiku a léčbu IMC, včetně pohlavních cest u mužů. Urol List. 2005; 3(2): 73.
    5. Hájková B. Infekce močových cest u seniorů. Čes Ger Rev. 2008; 6(1): 14-18.
    6. Colgan R, Mozella W, Johnson J. Diagnóza a léčba akutní pyelonefritidy u žen. Medicína po promoci. 2012; 13(1).
    7. Krieger J. Urinary tract infections. J Urol. 2002; 168(6): 2351-2358. Go to original source... Go to PubMed...
    8. Michaels E, Chmiel J, Plotkin B, Schaeffer A. Effect of D-mannose and D-glucose on Escherichia coli bacteriuria in rats. Urol Res. 1983; 11(2): 97-102. Go to original source... Go to PubMed...
    9. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women. World J Urol. 2014; 32(1): 79-84. Go to original source... Go to PubMed...
    10. Gouin S, Wellens A, Bouckaert J, Kovensky J. Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli. Chem Med. 2009; 4(5): 749-755. Go to original source...
    11. Ledda A, Bottari R, Luzzi G, Belcaro S, Hu P, et al. Cranberry supplementation in the prevention of non-severe lower urinary tract infections. Eur Rev Med Pharmacol Sci. 2015; 19(1): 77-80. Go to PubMed...
    12. Schmidr D, Sobota A. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios. 1988; (55): 173-181.
    13. Matoušková M, Rollová M. Imunomodulace probiotiky v léčbě recidivujících zánětů dolních močových cest. Čes urol. 2001; (4): 39.
    14. Urivac; příbalová informace. (online) dostupné z https://www.bioveta.cz/pripravky/humanni-pripravky/urivac-pribalova-informace-1/; 6-1-2018.
    15. The Role of the Pharmacist in Self-Care and Self-Medication. World Health Organization. [Online] 1998. dostupné z http://apps.who.int/medicinedocs/en/d/Jwhozip32e/4.html.18-12-2017
    16. Samoléčba. Sdružení výrobců volně prodejných léčiv. (Online) Dostupné z www: http://www.svopl.cz/samolecba;18-12-2017.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.